To erase cancer.
Erasca is a clinical-stage precision oncology company co-founded in 2018 with a singular mission to erase cancer. The company develops novel therapies targeting the RAS/MAPK pathway, the most frequently altered signaling pathway in cancer, using small molecules, large molecules, and protein degraders in combination to comprehensively shut down oncogenic signaling across multiple tumor types.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountMar 2019
Create a free account to see which investors have funded this company.
Create Free Account
Health insurance company using technology to make health care simple, affordable, and accessible.
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Outpatient mental health provider offering in-person and virtual therapy, psychiatry, and psychol...
Leading provider of diversified home and community-based health and pharmacy services to medicall...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Biopharmaceutical company developing sustained-release hydrogel therapies targeting retinal disea...
